Leukaemia Trial, Recruiting NCT06697275 Sponsor: University Hospital, Clermont-Ferrand Condition: Leukaemia
Back to Leukaemia

Leukaemia Trial, Recruiting

NCT06697275
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children aged 6 to 16 years old who have leukemia and need a needle inserted into an implantable port (a small medical device under the skin used to give treatments)
  • Children who are expected to live for 3 months or longer
  • Children and their parents who have been fully informed about the study and have agreed in writing to take part
  • Children who do not have any medical reasons that would prevent them from safely using MEOPA® (a pain-relieving gas mixture), such as needing 100% oxygen, having raised pressure in the brain, or having a reduced level of consciousness that prevents cooperation
  • Children who do not have any medical reasons that would prevent them from safely using a virtual reality headset, such as epilepsy or a psychiatric illness
  • Children and parents who are able to use the self-rating scales required by the study
  • Children enrolled in the French Social Security system

Who may not be able to join:

  • Children who have a condition that affects how they feel or process pain (for example, spina bifida)
  • Children who need to be kept separate from others due to an infectious condition (such as conjunctivitis or a contagious skin condition)
  • Children who have a history of seizures

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Alexandra USCLADE, University Hospital, Clermont-Ferrand

Phone: +33473754963

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
15 November 2024
Est. completion
1 October 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Children's pain self-evaluation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov